酸通过减轻前额叶氧化应激和糖尿病老鼠模型中的亡来改善记忆功能障碍

相关实验视频

Updated: Jun 12, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.4K

Ramadhea Laila Afifa An-Nur Willya Saputri1,2, Nur Arfian1, Junaedy Yunus1

  • 1Department of Anatomy, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Indonesia.

Turkish journal of medical sciences
|September 19, 2024
PubMed
概括

酸 (CGA) 可能通过增加额叶SOD1,SOD2和Bcl-2基因表达来增强糖尿病 (DM) 鼠的记忆力. 这项研究调查了CGA.

关键词:
基酸是一种基酸.莫里斯水迷宫是一个水迷宫.灭症 (apoptosis) 是一种死亡的过程.糖尿病 糖尿病患者 糖尿病患者氧化应激是一种氧化应激.

更多相关视频

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

7.4K
Barnes Maze Testing Strategies with Small and Large Rodent Models12:59

Barnes Maze Testing Strategies with Small and Large Rodent Models

Published on: February 26, 2014

41.8K

相关概念视频

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451